No Image added to Single-Image-Module
  • 18 Avenue de la Gare
  • L4131 Esch-sur Alzette
  • Luxembourg

BRUNO PEREIRA

SITUATION ACTUELLE

Médecin spécialiste en Cardiologie,
Activité répartie entre l’INCCI (Institut national de cardiologie interventionnelle et de chirurgie cardiaque) et le cabinet de consultation à Esch-sur-Alzette

COMPETENCES

Pratique de la cardiologie générale en consultation.
Réalisation d’échocardiographies transthoraciques, d’échodoppler des troncs supra-aortiques , de Holter tensionnels et ECG et d’épreuve d’efforts sur cycloergomètre.
Réalisation à l’INCCI de coronarographies, de cathétérismes cardiaques droits, d’angioplasties coronariennnes avec implantation de stents, de fermeture percutanée de foramen ovale perméable et de communication interauriculaire.
Domaine de prédilection en cardiologie interventionnelle: dilatations coronariennes complexes. (occlusions coronariennes chroniques, bifurcations, calcifications coronariennes)

EXPÉRIENCE

2015 -2017: membre du CMPMM INCCI-CHL.

2009 -2013: membre du CMPMM au CHEM.

2009 -2011: expert medical au LTPS Bascharage.

008 -2013: agrégation en tant que cardiologue avec le Centre Hospitalier Emile Mayrisch (CHEM) Esch/Alzette.

2007: cardiologue interventionnel à l’INCCI.

2007: Fellow en cardiologie interventionnelle au Sart-Timan, Liège, Belgique.

2002-2006 : Interne des Hôpitaux Univesitaires de Strasbourg, France.

FORMATION

2006: Diplôme d’Etat de Docteur en Médecine, Université de Strasbourg, France : summa cum laude

2006: Diplôme d’études spécialisées en maladies cardio-vasculaires, Université de Strasbourg, France

2005: Diplôme inter-universitaire d’échocardiographie et d’angiologie region Est Université de Strasbourg, France

FORMATIONS
COMPLEMENTAIRES

CTO, bifurcations, dilatations complexes, PCI robo-assistées
Fermeture percutanée des foramen ovale et des CIA
Dénervation rénale

MEMBERSHIPS

Luxembourg Society of Cardiology
Luxembourg Resuscitation Council
European Society of Cardiology

PUBLICATIONS
SCIENTIFIQUES

  1. Value of left atrial dilation in the diagnosis of silent myocardial ischemia in diabetes mellitus patients Pereira B, Morel O, Blondet C, Grunebaum L, Goichot B, Merrien N, Jesel L, Faure A, Trinh A, Vinzio S, Constantinesco A, Bareiss P. Ann Cardiol Angeiol 2008 Aug;57(4):201-12.
  2. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. Morel O, Pereira B, Averous G, Faure A, Jesel L, Germain P, Grunebaum L, Ohlmann P, Freyssinet JM, Bareiss P, Toti F. Atherosclerosis. 2009 Jun;204(2):636-41.
  3. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A. Eur Heart J. 2014 Oct 1;35(37):2541-619. National rewiewer
  4. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S; ESC Scientific Document Group . Eur Heart J. 2016 Jan 14;37(3):267-315. National rewiewer
  5. Antegrade wire escalation for chronic total occlusions in coronary arteries: simple algorithms as a key to success. Mearemans, Pereira B et al. J Cardiovasc Med . 2016 Sep;17(9):680-6.
  6. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P; ESC Scientific Document Group . Eur Heart J. 2018 Jan 7;39(2):119-177. National rewiewer
  7. One-year clinical and computed tomography follow-up after implantation of bioresorbable vascular scaffolds in patients with coronary chronic total occlusions. Maeremans J, Verhaert D, Pereira B, Frambach P, Van Mieghem C, Barbato E, Willems E, Vrolix M, Dens J. Catheter Cardiovasc Interv. 2018 Sep 1;92(3):488-496.
  8. Assessing the landscape of percutaneous coronary chronic total occlusion treatment in Belgium and Luxembourg: the Belgian Working Group on Chronic Total Occlusions (BWGCTO) registry. Maeremans J, Kayaert P, Bataille Y, Bennett J, Ungureanu C, Haine S, Vandendriessche T, Sonck J, Scott B, Coussement P, Dendooven D, Pereira B, Frambach P, Janssens L, Debruyne P, Van Mieghem C, Barbato E, Cornelis K, Stammen F, De Vroey F, Vercauteren S, Drieghe B, Aminian A, Debrauwere J, Carlier S, Coosemans M, Van Reet B, Vandergoten P, Dens JA; (On behalf of the BWGCTO Investigators). Acta Cardiol. 2017 Nov 28:1-10
  9. Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial. Rozemeijer R, Stein M, Frambach P, Voskuil M, Kraaijeveld AO, Rodríguez-Olivares R, Timmers L, Pereira B, Rittersma SZ, Agostoni P, Doevendans PA, Stella PR. Catheter Cardiovasc Interv. 2018 Feb 15;91(3):410-416.
  10. Outcomes of the amphilimus-eluting polymer-free stent for chronic total occlusion treatment: a multicentre experience. Maeremans J, Cottens D, Azzalini L, Pereira B, Godino C, Carlino M, Colombo A, Frambach P, Bellini B, Candilio L, Briguori C, Pierri A, Lamers S, Roux L, Duponselle J, Vrolix M, Dens J. J Cardiovasc Med 2018 Oct;19(10):564-570.
  11. 2018 ESC/EACTS Guidelines on myocardial revascularization Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; ESC Scientific Document Group . Eur Heart J. 2018 Aug 25 National rewiewer
  12. 2018 ESC/EACTS Guidelines on myocardial revascularization. Sousa-Uva M, Neumann FJ, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, iebauer J, Richter DJ, Seferovic PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO; Eur J Cardiothorac Surg. Eur Heart J. 2019 Jan 7;40(2):87-165
  13. Randomized All-Comers Evaluation of a Permanent Polymer Zotarolimus-Eluting Stent Versus a Polymer-Free Amphilimus-Eluting Stent: (ReCre8) A Multicenter, Non-Inferiority Trial. Rik Rozemeijer , Mera Stein , Michiel Voskuil , Rutger van den Bor , Peter Frambach , Bruno Pereira , Stefan Koudstaal , Geert E. Leenders , Leo L Timmers , Saskia Rittersma , Adriaan O Kraaijeveld , Pierfrancesco Agostoni , Kit Roes , Pieter A Doevendans , and Pieter R Stella. Circulation. 2019 Jan 2;139(1):67-77.
  14. Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study. Hommels TM, Hermanides RS, Rasoul S, Berta B, IJsselmuiden AJJ, Jessurun GAJ, Benit E, Pereira B, De Luca G, Kedhi E. Cardiovasc Diabetol. 2019 Mar 9;18(1):25.
  15. The 1year safety and efficacy outcomes of Absorb bioresorbable vascular scaffolds for coronary artery disease treatment in diabetes mellitus patients: the ABSORB DM Benelux study. Hommels TM, Hermanides RS, Rasoul S, Berta B, IJsselmuiden AJJ, Jessurun GAJ, Benit E, Pereira B, De Luca G, Kedhi E. Neth Heart J. 2019 Nov;27(11):541-549.
  16. The evolution of the CTO-PCI landscape in Belgium and Luxembourg: a four-year appraisal. Eertmans W, Kayaert P, Bennett J, Ungureanu C, Bataille Y, Saad G, Haine S, Coussement P, Pereira B, Agostoni P, Janssens L, Vandeloo B, Maréchal P, Cornelis K, de Hemptinne Q, Aminian A, Stammen F, Carlier S, Timmermans P, Vercauteren S, Sonck J, De Vroey F, Drieghe B, McCutcheon K, Scott B, Davin L, Gafari C, Dens J; BWGCTO Investigators. Acta Cardiol. 2020 Aug 5:1-9
  17. 3-Year Clinical Outcomes After Implantation of Permanent-Polymer Versus Polymer-Free Stent: ReCre8 Landmark Analysis N D van Hemert , M Voskuil, R Rozemeijer, M Stein, P Frambach, B Pereira , S Z Rittersma, A O Kraaijeveld, G E H Leenders , L Timmers, P van der Harst 1 , P Agostoni, P R Stella, ReCre8 Study Investigators JACC Cardiovasc Interv. 2021 Nov 22;14(22):2477-2486
  18. Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial. Kedhi E, Berta B, Roleder T, Hermanides RS, Fabris E, IJsselmuiden AJJ, Kauer F, Alfonso F, von Birgelen C, Escaned J, Camaro C, Kennedy MW, Pereira B, Magro M, Nef H, Reith S, Al Nooryani A, Rivero F, Malinowski K, De Luca G, Garcia Garcia H, Granada JF, Wojakowski W. Eur Heart J. 2021 Dec 1;42(45):4671-4679
  19. Thin-Cap Fibroatheroma Rather Than Any Lipid plaques Increases the Risk of Cardiovascular Events in Diabeti Patients: Insights From the COMBINE FFR-OCT Trial. Fabris E, Berta B, Roleder T, Hermanides R, IJsselmuiden A, Kauer F, Alfonso F, von Birgelen C, Escaned J, Camaro C, Kennedy M, Pereira B, Magro M, Nef H, Reith S, Roleder-Dylewska M, Gasior P, Malinowski K, De Luca G, Garcia H, Granada J, Wojakowski W, Kedhi E. Circulation Card Inter 2022 ahead to print
  20. Long term cardiovascular events in patients with normal fractional flow reserve and thin-cap fibroatheroma: extended follow up of the COMBINE OCT–FFR trial. Fabris E, Berta B, Roleder T, Hermanides R, IJsselmuiden A, Kauer F, Alfonso F, von Birgelen C, Escaned J, Camaro C, Kennedy M, Pereira B, Magro M, Nef H, Reith S, Roleder-Dylewska M, Gasior P, Malinowski K, De Luca G, Garcia H, Granada J, Wojakowski W, Kedhi E. Eurointervention 2022 ahead to print